Development of a Gene Therapy for Epilepsy

The Neurobiochemistry group at the Department of Pharmacology invites applications for a PhD student position within the doctoral college „Signal Processing in Neurons“ as of Summer 2017. Deadline for applications is March 31^th.

The position focuses on the development of a gene therapy for epilepsy. Neuropeptides and modified peptides will be analyzed in cell-based assays and animal models for their antiepileptic and disease-modifying properties and their potential for side effects.

The position is financed for 36 months with the possibility to extend for an additional year after positive evaluation. The necessary funding has been secured. Salary will be in accordance with the regulations of the Austrian Science Fund. Compensation includes health insurance and vacation time.

The entire PhD training is in compliance with the Bologna criteria for an international PhD and will be provided in English. Attendance and data presentations at international and national meetings will be supported.

Your profile:

You are highly motivated and hold a Master or Diploma degree in neurosciences, biology, pharmacy or medicine.

You have a strong interest in interdisciplinary research with a focus on neuroscience.

You have a very good command of English and strong organizational skills.

You have didactic skills and are willing to contribute to the training and education of fellow students.

Previous experience in research activities and experience in the analysis of (EEG) data including statistics are of advantage but not a precondition

For further information on the program and our research please refer to our websites.

http://www.neurospin.at/content/home

https://www.i-med.ac.at/pharmakologie/forschung/research_schwarzer.html

Institution:

Medical University of Innsbruck

Department of Pharmacology

Contact Information

A/Prof. Dr. Christoph Schwarzer

Department of Pharmacology

Peter-Mayr-Str. 1a

6020 Innsbruck

Austria

Schwarzer.Christoph@i-med.ac.at